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INTRODUCTION:  Hemangioblastomas  are  benign,  slow  growing  but  highly  vascularized  tumors  of  the
central  nervous  system,  with  the  most  common  location  of  occurrence  in  the  posterior  fossa.  Heman-
gioblastomas  usually  have  an  associated  with  patients  that  have  Von-Hippel  Lindau  disease,  resulting  a
germline  mutation  in  the  VHL  tumor  suppressor  gene.  Isolated  or sporadic  occurrences  of  hemangioblas-
tomas  are  much  more  infrequent  and  typically  respond  well  after  surgery.
PRESENTATION  OF  CASE:  We  present  case  of a 22  year  old  female  with  worsening  shoulder  pain,  decreased
sensation  in  the  hands  and  feet,  and  decreasing  strength  and  was  found  to have  a  hemangioblastoma  ofon-Hippel Lindau
ascular tumor
aminectomy
yelotomy
ase report
the cervical  spine.
DISCUSSION:  The  patient  was  treated  with  surgery  and responded  well  to treatment.  We  also  present  a
review  of  the literature  on  isolated  occurrences  of hemangioblastomas  of the  spinal  cord.
CONCLUSION:  Isolated  hemangioblastoma  are  a rare  tumor  of  the  central  nervous  system  and  can  be
managed  with  surgery.
Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open  access  article  under
the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Hemangioblastomas are highly vascularized but benign tumors
f the central nervous system [1]. These tumors can contain
ndothelial cells, pericytes, and stromal cells. Many of these cases
f hemangioblastomas are sporadic, but an estimated 10–40 per-
ent are associated with a germline mutation of the Von-Hippel
indau (VHL) tumor suppressor gene [2]. In patients with sporadic
nd isolated hemangioblastomas, only four percent of patients had
 detectable mutation in the VHL gene; however, these mutations
C162Y, D179N and R200W (in two patients)) were deemed to be
emangioblastoma-only or low penetrance mutations [3].
Hemangioblastomas can occur anywhere along the central ner-
ous system such as the brain [4–6], optic nerve [7], retina [8],
nd spinal cord [9]. Considering the slow growing nature of these
umors, for patients that are asymptomatic, patients can be fol-
owed solely by observation. For the symptomatic patient, surgery
s the preferred option, allowing for a complete resection with
ccompanying pathological analysis. In this report, we  present a
∗ Corresponding author at: Department of Radiation Oncology, UT Southwestern
edical Center, Dallas, TX 75390, United States.
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210-2612/Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open a
y-nc-nd/4.0/).case of a 22 year old female who presented with bilateral upper
extremity weakness and paresthesias and was  found to have a
1.5 centimeter mass in the C5–C6 disc space with an extensive
syrinx extending inferior to the level of T8. We present the clinical
presentation of the patient, the operative/surgical management of
the patient, and a literature review of sporadic hemangioblastomas
of the spinal cord.
2. Case description
2.1. Preoperative information
A 22 year old African American female initially presented with
decreased strength in her both hands, with the right worse than the
left. She also endorsed pain in both of her shoulders. On examina-
tion, the patient had decreased sensation in both arms. The patient
did not endorse any symptoms consistent with any lower spine
pathology such as lower extremity weakness, bladder dysfunction,
or sphincter dysfunction. The patient received a magnetic reso-
nance imaging study of the cervical and thoracic spine that revealed
a cervical canal/cord mass (Fig. 1). The mass is a focal lesion in the
posterior C5–C6 disc space, measuring approximately in 1.3 × 1.0
centimeter, with extensive syrinx that terminates at the level of
T8. The lesion appears to have a solid and cystic component with
ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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Fig. 1. Magnetic resonance imaging of the cervical cord of the hemangioblastoma upon admission. A 1.3 cm lesion is visualized in the posterior C5–C6 disc space, containing
solid  and cystic components with possible products of hemorrhage. An enlarged spinal cord with syrinx is visualized that tracks inferiorly to the thoracic cord. (A) Axial
post-contrast T1 sequence at the level of C5; (B) Axial T2 sequence at the level of C5; (C) Sagittal post-contrast T1 sequence at the mid-sagittal line; (D) Sagittal T2 sequence
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ossible products of hemorrhage. Magnetic resonance imaging of
he lumbar spine and brain were largely unremarkable. The patient
eceived an angiogram of the cervical spine that showed a markedly
ypervascular intramedullary mass at the C5-6 level that corre-
ponds to the abnormality seen on the magnetic resonance imaging
ith features, suggestive of ependymoma and hemangioblastoma.
.2. Operative intervention and surgery
The patient then underwent a decompressive posterior cervical
aminectomy of C4–C7 with fenestration of the syrinx, myelotomy
ith CO2 laser, and resection of the tumor. A midline excision was
ade from the spinous process of C7/T1 and extended superiorly
o approximately the level of C4. A C4 through C7 laminectomy
as then performed after intraoperative ﬂuoroscopy conﬁrmed
he location of the laminectomy. Then, the dura was  opened in
he midline, and the cervical cord was visualized to be extremely
wollen. Using a CO2 laser, a posterior myelotomy was performed,
own to the medial inferior aspect of the syrinx. After resection
nd hemostasis was achieved, the dura was closed, and a dural
egeneration matrix was overlaid. Then, a posterior lateral onlay
usion with bone marrow aspirate, autologous bone, demineral-
zed bone matrix, and stem cell bone matrix was placed from thelevel of C4 through T1. Somatosensory evoked response monitor-
ing/electromyography showed baseline activities.
2.3. Surgical pathology
Tumor samples were collected in ﬁve pieces and were also
reviewed at an outside institution. The surgical pathology returned
as hemangioblastoma, World Health Organization grade I, with
positive immunostaining for inhibin.
2.4. Postoperative course
After surgery, the patient was  cared in the surgical intensive
care unit with cervical spine precautions and placed on dexam-
ethasone. The patient had 0/5 intrinsic strength in the bilateral
upper extremity but was  able to regain the majority of her strength
in the immediate days after surgery. The patient received evalua-
tion and treatment from physical therapy with adequate progress.
Due to the socioeconomic status of the patient, the patient was
discharged to a skilled nursing facility for continued rehabilita-
tion, instead of her home. In the skilled nursing facility, the patient
demonstrated improved strength with therapy. In the months fol-
lowing discharge, the patient continued to have improved strength
and sensation. The patient was evaluated by medical and radiation
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Fig. 2. Magnetic resonance imaging of the cervical cord of the hemangioblastoma, three months after surgery. Following imaging shows stable post-operative changes and
resection of the C5–C6 mass, with a small 2 mm focus of enhancement in the posterior cord, unlikely to be a tumor recurrence and likely a post-operative artifact. (A) Axial
post-contrast T1 sequence at the level of C5; (B) Axial T2 sequence at the level of C5; (C) Sagittal post-contrast T1 sequence at the mid-sagittal line; (D) Sagittal T2 sequence
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ncology, who did not recommend adjuvant therapy, especially
onsidering the slow growing nature of hemangioblastomas. A fol-
ow up magnetic resonance imaging of the cervical spine three
onths after surgery demonstrated stable post-operative changes
ithout any features of residual or recurrent tumor growth (Fig. 2).
. Discussion
Hemangioblastomas are a rare entity overall with the most com-
on  location for an occurrence of hemangioblastoma is in the
osterior cranial fossa [10]. The second most frequent location
s the spinal cord [11]. However, spinal cord hemangioblastomas
nly account for a small percentage of primary spinal cord tumors
verall. Moreover, most descriptions of spinal cord hemangioblas-
omas are discussed in the context of a patient with Von-Hippel
indau disease [12]. It is unknown how many isolated or spo-
adic spinal cord hemangioblastomas have occurred [13–19]. One
tudy showed that spinal hemangioblastomas are sporadic in only
pproximately 20 percent of cases [20]. Patients with sporadic
emangioblastomas present much later in life, have less neurolog-
cal symptoms, and have a better prognosis than their Von-Hippel
indau counterparts [20,21]. Patients with Von-Hippel Lindau are
t a higher risk of recurrence as well, requiring lifelong follow up
nd surveillance [21].Current National Comprehensive Cancer Network guidelines
recommend that patients who present with a primary spinal cord
tumor undergo observation if the patient is asymptomatic but
surgery if the patient is symptomatic. The rationale behind surgery
is two-fold. First, patients who  have primary spinal cord tumors
and undergo surgical resection have acceptable rates of neuro-
logical improvements [22]. Second, surgery allows for the direct
acquisition of tissue to conﬁrm the diagnosis of hemangioblas-
toma. Imaging alone makes it difﬁcult to ascertain neoplastic versus
non-neoplastic conditions, requiring the reading radiologist to dis-
cern among different magnetic resonance signals [23]. Moreover,
immunostaining can distinguish between metastatic renal cell car-
cinoma versus hemangioblastoma, especially in a patient with
Von-Hippel Lindau disease [24,25]. Radiation therapy has also been
proposed as a treatment modality, with a great deal of success
[26–29]. However, we argue against radiation therapy since it
would be difﬁcult to treat a patient with certainty and curative
intent without a deﬁnitive pathological diagnosis of the disease.
Bevacizumab is a monoclonal antibody directed against vascular
endothelial growth factor A that can block angiogenesis. It has been
previously used in various oncological applications. One report
described its use in a patient with a surgically unresectable cervical
cord hemangioblastoma, showing signiﬁcant tumor regression and
clinical improvement [30].
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. Conclusions
Hemangioblastomas are a rare benign, slow growing vascular
umor of the central nervous system. We  present a 22 year old
atient who presented with bilateral upper extremity symptoms
nd had a sporadic hemangioblastoma of the spinal cord who  was
reated with surgery, not requiring any adjuvant therapy. The neu-
ologic function improved in the days and months after surgery.
e surmise that our experience is concordant with the few experi-
nces reported in the literature and recommend expedited surgical
nd operative intervention for the treatment of these patients.
onsent
Written informed consent was obtained from the patient for
ublication of this case report and accompanying images. A copy
f the written consent is available for review by the Editor-in-Chief
f this journal on request.
onﬂicts of interest
The authors declare no conﬂicts of interest, relevant ﬁnancial
elationships, or any sources of support in the form of grants, equip-
ent, or drugs.
unding
No sources of funding are declared.
thical approval
Ethical approval has been given from the John Peter Smith
epartment of Neurosurgery.
uthor contributions
Conception and design: Robert E. Germann, George F. Cravens;
cquisition of data: Robert E. Germann, George F. Cravens; Analysis
nd interpretation of the data: all authors; Drafting the article: Dat
. Vo; Critically revising the article: all authors; Approved the ﬁnal
ersion of the manuscript on behalf of all authors: Dat T. Vo; Study
upervision: George F. Cravens.
uarantor
All of the authors listed in the manuscript accept full responsi-
ility for the work and conduct of this study.
eferences
[1] D. Catapano, L.A. Muscarella, V. Guarnieri, L. Zelante, V.A. D’Angelo, L.
D’Agruma, Hemangioblastomas of central nervous system: molecular genetic
analysis and clinical management, Neurosurgery 56 (2005) 1215–1221
(discussion 1221, published online EubJun).
[2] R.R. Lonser, G.M. Glenn, M.  Walther, E.Y. Chew, S.K. Libutti, W.M.  Linehan, E.H.
Oldﬁeld, von Hippel-Lindau disease, Lancet 361 (2003) 2059–2067, http://dx.
doi.org/10.1016/s0140-6736(03)13643-4 (published online EubJun 14).
[3] E.R. Woodward, K. Wall, J. Forsyth, F. Macdonald, E.R. Maher, VHL mutation
analysis in patients with isolated central nervous system
haemangioblastoma, Brain: a journal of neurology 130 (2007) 836–842,
http://dx.doi.org/10.1093/brain/awl362 (published online EubMar).
[4]  M.L. Silver, G. Hennigar, Cerebellar hemangioma (hemangioblastoma); a
clinicopathological review of 40 cases, J. Neurosurg. 9 (1952) 484–494, http://
dx.doi.org/10.3171/jns.1952.9.5.0484 (published online EubSe).
[PEN  ACCESS
rgery Case Reports 26 (2016) 7–11
[5] M.F. Acikalin, U. Oner, N. Tel, O. Pasaoglu, F. Altinel, Supratentorial
hemangioblastoma: a case report and review of the literature, Arch. Pathol.
Lab. Med. 127 (2003) e382–e384, http://dx.doi.org/10.1043/1543-
2165(2003)127<e382:SHACRA>2.0.Co;2 (published online EpubSep).
[6] A.A. Stein, A.O. Schilp, R.D. Whitﬁeld, The histogenesis of hemangioblastoma
of  the brain. A review of twenty-one cases, J. Neurosurg. 17 (1960) 751–761,
http://dx.doi.org/10.3171/jns.1960.17.4.0751 (published online EubJul).
[7] J.A. Nerad, R.C. Kersten, R.L. Anderson, Hemangioblastoma of the optic nerve.
Report of a case and review of literature, Ophthalmology 95 (1988) 398–402
(published online EpubMar).
[8] H. Dollfus, P. Massin, P. Taupin, C. Nemeth, S. Amara, S. Giraud, C. Beroud, P.
Dureau, A. Gaudric, P. Landais, S. Richard, Retinal hemangioblastoma in von
Hippel-Lindau disease: a clinical and molecular study, Investig. Ophthalmol.
Visual Sci. 43 (2002) 3067–3074 (published online EpubSep).
[9] T.R. Browne, R.D. Adams, G.H. Roberson, Hemangioblastoma of the spinal
cord. Review and report of ﬁve cases, Arch. Neurol. 33 (1976) 435–441
(published online EpubJun).
10] H.P. Neumann, H.R. Eggert, K. Weigel, H. Friedburg, O.D. Wiestler, P.
Schollmeyer, Hemangioblastomas of the central nervous system. A 10-year
study with special reference to von Hippel-Lindau syndrome, J. Neurosurg. 70
(1989) 24–30, http://dx.doi.org/10.3171/jns.1989.70.1.0024 (published online
EubJan).
11] T. Murota, L. Symon, Surgical management of hemangioblastoma of the spinal
cord: a report of 18 cases, Neurosurgery 25 (1989) 699–707 (discussion 708,
published online EpubNov).
12] T.D. Kinney, P.J. Fitzgerald, Lindauvon Hippel disease with hemangioblastoma
of  the spinal cord and syringomyelia, Arch. Pathol. 43 (1947) 439–455
(published online EpubMay).
13] P. Lunardi, L. Cervoni, A. Maleci, A. Fortuna, Isolated haemangioblastoma of
spinal cord: report of 18 cases and a review of the literature, Acta Neurochir.
(Wien) 122 (1993) 236–239.
14] C. Roonprapunt, V.M. Silvera, A. Setton, D. Freed, F.J. Epstein, G.I. Jallo, Surgical
management of isolated hemangioblastomas of the spinal cord, Neurosurgery
49 (2001) 321–327 (discussion 327–328, published online EpubAug).
15] R.R. Lonser, Surgical management of sporadic spinal cord
hemangioblastomas, World Neurosurg. 82 (2014) 632–633, http://dx.doi.org/
10.1016/j.wneu.2014.08.026 (published online EubNov).
16] L.A. Snyder, R.F. Spetzler, Resection of sporadic spinal hemangioblastomas,
World Neurosurg. 82 (2014) 629–631, http://dx.doi.org/10.1016/j.wneu.2014.
06.055 (published online EubNov).
17] H.I. Sun, K. Ozduman, M.I. Usseli, S. Ozgen, M.N. Pamir, Sporadic spinal
hemangioblastomas can be effectively treated by microsurgery alone, World
Neurosurg. 82 (2014) 836–847, http://dx.doi.org/10.1016/j.wneu.2014.05.024
(pulished online EubNov).
18] C.H. Park, C.H. Lee, S.J. Hyun, T.A. Jahng, H.J. Kim, K.J. Kim, Surgical outcome of
spinal cord hemangioblastomas, J. Korean Neurosurg. Soc. 52 (2012) 221–227,
http://dx.doi.org/10.3340/jkns.2012.52.3.221 (published online EubSe).
19] A. Bostrom, F.J. Hans, P.C. Reinacher, T. Krings, U. Burgel, J.M. Gilsbach, M.H.
Reinges, Intramedullary hemangioblastomas: timing of surgery, microsurgical
technique and follow-up in 23 patients, Eur. Spine J. 17 (2008) 882–886,
http://dx.doi.org/10.1007/s00586-008-0658-1 (published online EpubJun).
20] K. Takai, M.  Taniguchi, H. Takahashi, M.  Usui, N. Saito, Comparative analysis of
spinal hemangioblastomas in sporadic disease and Von Hippel-Lindau
syndrome, Neurol. Med. Chir. (Tokyo) 50 (2010) 560–567.
21] J.E. Conway, D. Chou, R.E. Clatterbuck, H. Brem, D.M. Long, D. Rigamonti,
Hemangioblastomas of the central nervous system in von Hippel-Lindau
syndrome and sporadic disease, Neurosurgery 48 (2001) 55–62 (discussion
62–53, published online EpubJan).
22] S. Yang, X. Yang, G. Hong, Surgical treatment of one hundred seventy-four
intramedullary spinal cord tumors, Spine 34 (2009) 2705–2710, http://dx.doi.
org/10.1097/brs.0b013e3181b43484 (published online EubNov 15).
23] D.D. Do-Dai, M.K. Brooks, A. Goldkamp, S. Erbay, R.A. Bhadelia, Magnetic
resonance imaging of intramedullary spinal cord lesions: a pictorial review,
Curr. Probl. Diagn. Radiol. 39 (2010) 160–185, http://dx.doi.org/10.1067/j.
cpradiol.2009.05.004 (published online EubJul-Aug).
24] A.D. Polydorides, M.K. Rosenblum, M.A. Edgar, Metastatic renal cell carcinoma
to  hemangioblastoma in von Hippel-Lindau disease, Arch. Pathol. Lab. Med.
131 (2007) 641–645, http://dx.doi.org/10.1043/1543-
2165(2007)131[641:MRCCTH]2.0.CO;2 (published online EpubApr).
25] A.L. Rivera, H. Takei, J. Zhai, S.S. Shen, J.Y. Ro, S.Z. Powell, Useful
immunohistochemical markers in differentiating hemangioblastoma versus
metastatic renal cell carcinoma, Neuropathology 30 (2010) 580–585, http://
dx.doi.org/10.1111/j.1440-1789.2010.01109.x (published online EubDec).
26] M.T. Selch, S. Tenn, N. Agazaryan, S.P. Lee, A. Gorgulho, A.A. De Salles,
Image-guided linear accelerator-based spinal radiosurgery for
hemangioblastoma, Surg. Neurol. Int. 3 (2012) 73, http://dx.doi.org/10.4103/
2152-7806.98386.
27] U.K. Chang, C.H. Rhee, S.M. Youn, D.H. Lee, S.Q. Park, Radiosurgery using the
Cyberknife for benign spinal tumors: Korea Cancer Center Hospital
experience, J. Neurooncol. 101 (2011) 91–99, http://dx.doi.org/10.1007/
s11060-010-0231-8 (published online EpubJan).
28] J.M. Moss, C.Y. Choi, J.R. Adler Jr., S.G. Soltys, I.C. Gibbs, S.D. Chang, Stereotactic
radiosurgical treatment of cranial and spinal hemangioblastomas,
Neurosurgery 65 (2009) 79–85, http://dx.doi.org/10.1227/01.neu.
0000348015.51685.D2 (discussion 85, published online EubJul).
 –  O
l of Su
[
O
T
p
cCASE  REPORT
D.T. Vo et al. / International Journa29] E.S. Koh, A. Nichol, B.A. Millar, C. Menard, G. Pond, N.J. Laperriere, Role of
fractionated external beam radiotherapy in hemangioblastoma of the central
nervous system, Int. J. Radiat. Oncol. Biol. Phys. 69 (2007) 1521–1526, http://
dx.doi.org/10.1016/j.ijrobp.2007.05.025 (published online EpubDec 1).
[
pen Access
his article is published Open Access at sciencedirect.com. It is distrib
ermits unrestricted non commercial use, distribution, and reproduct
redited.PEN  ACCESS
rgery Case Reports 26 (2016) 7–11 11
30] A.I. Omar, Bevacizumab for the treatment of surgically unresectable cervical
cord hemangioblastoma: a case report, J. Med. Case Rep. 6 (2012) 238, http://
dx.doi.org/10.1186/1752-1947-6-238.
uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
